Cachectin and tumour necrosis factor as two sides of the same biological coin.
about
Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 betaMacrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic propertiesA novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignmentMutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infectionMedical immunology: a new journal for a new subspecialty.Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expressionDecreased Jun-D and myogenin expression in muscle wasting of human cachexiaOsteoimmunology: interactions of the bone and immune systemLipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophagesTLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humansGreen tea polyphenol extract attenuates lung injury in experimental model of carrageenan-induced pleurisy in miceEarly life programming of pain: focus on neuroimmune to endocrine communicationTNF biology, pathogenic mechanisms and emerging therapeutic strategiesBacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblastsMouse models for pathogenic African trypanosomes: unravelling the immunology of host-parasite-vector interactions.Mechanisms of metabolic dysfunction in cancer-associated cachexiaInhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signalingAlkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effectsCytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteineAntenatal dexamethasone suppresses tumor necrosis factor-alpha expression in hypoplastic lung in nitrofen-induced diaphragmatic hernia in ratsImpaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient miceInvolvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokinesRecombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factorInhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline.Tumour necrosis factor inhibitors reduce the acute-phase response in hapten-induced colitis.Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibitionIndications, technical considerations, and strategies for renal replacement therapy in the intensive care unit.An interleukin-6-induced acute-phase response does not confer protection against lipopolysaccharide lethality.A synthetic analog of the 3-deoxy-D-manno-2-octulosonic acid disaccharide moiety of rough-type endotoxins does not bind to mouse peritoneal macrophages and human monocytesIncreased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral ReservoirsInteraction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer.Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cellsGeneration of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor.Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils.Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatusCoordinate viral induction of tumor necrosis factor alpha and interferon beta in human B cells and monocytesIdentification and characterization of a membrane-bound cytotoxin of murine cytolytic lymphocytes that is related to tumor necrosis factor/cachectin
P2860
Q21999071-EBF1237B-7B9A-4731-BF42-2A4551567784Q21999072-88449F70-5AAC-47DF-9F6E-B11C68F6F4D9Q22009378-11899033-45E0-4292-B15A-C7B19F8C8A50Q24322505-940FC6B0-6F07-4D73-A467-CAD93D27FC25Q24538980-BA069A14-645D-4C72-A4C1-550ED8BCB333Q24563012-B76BCE7B-C779-41C7-A024-8265C559EFF6Q24654557-377B787E-B6E1-498A-A9C5-2A2185A14169Q24655113-2330286B-FEAB-414C-9A7B-1FDB837A9EA1Q24678321-89F56146-5596-4A78-8FEC-33C1BD5AEAC0Q24678506-6DAFBCC7-9C30-4843-A80F-E9B0BD228925Q24813778-01C3E582-46A9-4D34-8293-C1055FCA27C8Q26751421-5AA95BCE-E637-4FDB-B648-E6A85688A23BQ26776492-50B8DA63-0989-4F19-9280-88DD8242466BQ27485094-FFD6EDB9-A452-4638-A501-CC40DBECD5D0Q27686928-88C20578-9428-456D-A575-1F248655898BQ28079213-2D8CBB2A-67C6-408C-9FC3-7C93BCE179B6Q28140492-83371B32-6026-430B-9522-C02AB88F41BDQ28302804-EFCF9C75-1A9D-4B35-9332-CD308498F1ADQ28329402-8742AC00-95AD-4C50-BD6B-20E457755EB2Q28375421-01259735-1FA1-48D5-944B-6C7D3B815D9CQ28513992-D4AA7970-F7A0-4F60-87D7-DA11CF84887DQ28646316-F86C5866-CF25-4AA2-ACB9-B54F63909590Q30449817-4A89D7A1-92F9-44C5-A1DC-F734256B66A2Q30451069-A9A8915E-A861-4011-96F1-180AA2B7EE01Q31893934-FEEFB7DC-3B16-42E0-9ECA-E055D81A70B6Q33269174-B60AD848-3CC3-4C8B-B99A-AAA328E23829Q33449039-D659DF55-33EE-432A-85BB-45C8D051C8A7Q33561712-0FE3CA54-8D99-476A-892F-7AD3DB9BF217Q33604280-CB0B1F40-5F5E-45F7-9C31-69062FCB1B2CQ33607039-1332C258-AF9B-4325-8B7B-C1A41AE4A4E5Q33611681-8E118A63-521D-439D-8F6D-0E7D26D6D616Q33613493-E001D68D-2CAD-41D6-9E1C-B8CA7E62EB64Q33614335-F6E7CBF2-82C2-486F-AEB5-5295E64011CEQ33632011-CEF7932C-22D1-4F8F-AD45-B81EDB2AC0FCQ33648545-25155C37-0C0A-42A5-A171-2489EFC29369Q33673534-9DEE3748-EA44-45D6-BBC4-F0E1193E6B97Q33681740-11347E77-92A2-4338-8BBC-30EF1D8B2D46Q33769906-28B0D61E-06C0-4DEC-B43C-D87EB84DA108Q33839633-A82EA8A0-6EC0-452E-BDBB-AA63F6E9A564Q33853958-F89DBF98-09C8-48B9-94A5-2FB5C34F5FBF
P2860
Cachectin and tumour necrosis factor as two sides of the same biological coin.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Cachectin and tumour necrosis factor as two sides of the same biological coin.
@en
Cachectin and tumour necrosis factor as two sides of the same biological coin.
@nl
type
label
Cachectin and tumour necrosis factor as two sides of the same biological coin.
@en
Cachectin and tumour necrosis factor as two sides of the same biological coin.
@nl
prefLabel
Cachectin and tumour necrosis factor as two sides of the same biological coin.
@en
Cachectin and tumour necrosis factor as two sides of the same biological coin.
@nl
P356
P1433
P1476
Cachectin and tumour necrosis factor as two sides of the same biological coin.
@en
P2093
P2888
P304
P356
10.1038/320584A0
P407
P577
1986-04-01T00:00:00Z
P6179
1026920872